MX2024003940A - Proteinas de la subunidad p40 de interleucinas modificadas y metodos para su uso. - Google Patents

Proteinas de la subunidad p40 de interleucinas modificadas y metodos para su uso.

Info

Publication number
MX2024003940A
MX2024003940A MX2024003940A MX2024003940A MX2024003940A MX 2024003940 A MX2024003940 A MX 2024003940A MX 2024003940 A MX2024003940 A MX 2024003940A MX 2024003940 A MX2024003940 A MX 2024003940A MX 2024003940 A MX2024003940 A MX 2024003940A
Authority
MX
Mexico
Prior art keywords
methods
modified interleukin
subunit proteins
protein
interleukin
Prior art date
Application number
MX2024003940A
Other languages
English (en)
Spanish (es)
Inventor
Von Kreudenstein Thomas Spreter
Ryan Blackler
Original Assignee
Zymeworks Bc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymeworks Bc Inc filed Critical Zymeworks Bc Inc
Publication of MX2024003940A publication Critical patent/MX2024003940A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5434—IL-12
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/50—Mutagenesis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • G16B35/10—Design of libraries

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MX2024003940A 2021-09-29 2022-09-29 Proteinas de la subunidad p40 de interleucinas modificadas y metodos para su uso. MX2024003940A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163249685P 2021-09-29 2021-09-29
PCT/CA2022/051445 WO2023050006A1 (en) 2021-09-29 2022-09-29 Modified interleukin p40 subunit proteins and methods of use thereof

Publications (1)

Publication Number Publication Date
MX2024003940A true MX2024003940A (es) 2024-04-22

Family

ID=85780291

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024003940A MX2024003940A (es) 2021-09-29 2022-09-29 Proteinas de la subunidad p40 de interleucinas modificadas y metodos para su uso.

Country Status (9)

Country Link
US (1) US20240228567A1 (enExample)
EP (1) EP4408870A4 (enExample)
JP (1) JP2024535925A (enExample)
KR (1) KR20240068070A (enExample)
CN (1) CN118043343A (enExample)
AU (1) AU2022355496A1 (enExample)
CA (1) CA3232071A1 (enExample)
MX (1) MX2024003940A (enExample)
WO (1) WO2023050006A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200089312A (ko) 2017-11-28 2020-07-24 추가이 세이야쿠 가부시키가이샤 리간드 결합 활성을 조정 가능한 리간드 결합 분자
EP3981428A4 (en) 2019-06-05 2023-07-12 Chugai Seiyaku Kabushiki Kaisha Protease substrate, and polypeptide including protease cleavage sequence
CN115943210A (zh) 2020-01-20 2023-04-07 中外制药株式会社 配体结合融合蛋白
AU2024407051A1 (en) 2023-12-18 2026-07-30 Genzyme Corporation Il-12 loss of potency muteins
WO2025151752A1 (en) 2024-01-10 2025-07-17 Xilio Development, Inc. Masked il-2 cytokines and methods of use thereof
WO2026020161A1 (en) 2024-07-19 2026-01-22 Cytomx Therapeutics, Inc. Activatable il-12 constructs and related compositions and methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102884523B1 (ko) * 2018-10-03 2025-11-10 젠코어 인코포레이티드 IL-12 이종이량체 Fc-융합 단백질
MX2022011676A (es) * 2020-03-23 2023-03-08 Zymeworks Bc Inc Proteinas de fusion de il12 con enmascaramiento y metodos para su uso.

Also Published As

Publication number Publication date
EP4408870A4 (en) 2025-10-22
CN118043343A (zh) 2024-05-14
EP4408870A1 (en) 2024-08-07
US20240228567A1 (en) 2024-07-11
KR20240068070A (ko) 2024-05-17
JP2024535925A (ja) 2024-10-02
CA3232071A1 (en) 2023-04-06
AU2022355496A1 (en) 2024-05-02
WO2023050006A1 (en) 2023-04-06

Similar Documents

Publication Publication Date Title
MY206158A (en) Antibody-cytokine engrafted proteins and methods of use in the treatment of cancer
PH12020500648A1 (en) Il-15 variants and uses thereof
ZA202203254B (en) Immunocytokine comprising heterodimeric protein complex based on il-15/il-15rα
MX2023001256A (es) Proteínas que comprenden dominios de unión al antígeno hla-g y sus usos.
MX2020010910A (es) Proteinas de fusion heterodimericas dirigidas a pd-1 que contienen proteinas de fusion il-15 / il-15ra fc y dominios de union al antigeno pd-1 y usos de los mismos.
WO2021181233A3 (en) Cd80-fc fusion protein and uses thereof
ATE226086T1 (de) Interleukin-2 analoge mit niedriger toxizität zur verwendung in der immuntherapie
UA84387C2 (ru) Человеческий цитокин как лиганд зальфа рецептора и его применение
MX2019010458A (es) Anticuerpos anti-gitr y metodos de uso de los mismos.
DK1572748T3 (da) Humaniseret antistof (H14.18) af muse-14.18-antistof der binder til GD2 og dets fusionsprotein med IL-2
WO2025010377A3 (en) Methods of using anti-sp17 immunotherapeutics
WO2008026071A3 (en) Treatment of cervical carcinoma with a recombinant adenylate cyclase carrying hpv antigens
WO2022026360A3 (en) Monoclonal antibodies against lilrb1 for diagnostic and therapeutic use
NZ590991A (en) Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof
MX2024004763A (es) Citocinas heterodimericas fc y usos de las mismas.
PH12021552148A1 (en) Cd3 binding molecules
WO2025010376A3 (en) Nucleic acids, vectors, and cells that encode anti-sp17 antibodies and other sp17 binding proteins
AU2021403658A9 (en) Recombinant cd3 binding proteins and their use
MX2022013288A (es) Composiciones y metodos para el tratamiento de proteinopatias por la proteina 43 de union a acido desoxirribonucleico (adn) de respuesta transactiva (tdp-43).
ZA202408121B (en) Anti-human il-4ra antibody and application thereof
JOP20210111A1 (ar) نظائر عامل gdf15 وطرق استخدامه في تقليل وزن الجسم و/أو تخفيض امتصاص الطعام
CO2025009742A2 (es) Tratamiento de la enfermedad autoinmunitaria
MX2024014105A (es) Proteinas de union a ptk7 con union dependiente de ph y usos de las mismas
MX2023005346A (es) Anticuerpo biespecifico anti-tspan8/anti-cd3 y anticuerpo anti-tspan8.
MX2021006922A (es) Constructo multigenico para la expresión de proteínas inmunoduladoras y métodos de uso.